Novartis provides science-based, innovation-driven healthcare solutions that address the evolving needs of patients and societies. Its products prevent and treat diseases, ease suffering and enhance quality of life. Novartis focuses on growing healthcare sectors where innovation plays an important role: pharmaceuticals, eye care, generic medicines, over-the-counter medicines, vaccines and animal health. It is the only company with strong positions in each of these areas. Research at Novartis is driven by a distinctive clinical and scientific strategy to address unmet medical needs and advance knowledge of disease. Corporate responsibility is an integral part of how Novartis operates and is key to its success. The company works to improve access to healthcare, and its Malaria Initiative has become one of the largest access-to-medicine programmes in the healthcare industry, as measured by patients reached. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 133,000 associates and operate in more than 140 countries around the world.